SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transoceans pending Valaris merger and offshore contract growth are driving discussion, with traders pointing to regulatory progress, rising day rates and a larger backlog as potential supports for the combined company. Bullish hopes for a short squeeze and improved earnings are tempered by concerns about merger dilution, heavy debt and RIGs inconsistent share-price action.

Starbucks Corp. engages in the production, marketing, and retailing of specialty coffee. It operates through the following segments: North America, International, and Channel Development. The North America segment focuses on the United States and Canada. The International segment is involved in China, Japan, Asia Pacific, Europe, Middle East, Africa, Latin America, and Caribbean. The Channel Development segment includes roasted whole bean and ground coffees, Seattle’s Best Coffee, and Teavana-branded single-serve products. The company was founded by Jerry Baldwin and Howard D. Schultz on November 4, 1985, and is headquartered in Seattle, WA.

Starbucks Corp.

Starbucks Corp

Starbucks quarterly results and outlook are driving discussion: earnings and comparable sales beat expectations, but revenue missed, with the China restructuring weighing on reported sales, and shares declined. Bulls point to improving U.S. traffic and turnaround progress, while bears focus on the revenue miss, soft reported growth outlook and valuation.

NANO Nuclear Energy, Inc. is a microreactor and nuclear technology company, which provides supply energy services. Its products in technical development are ZEUS, a solid core battery reactor, and ODIN, a low-pressure coolant reactor. The company is founded by Jiang Yu in February, 2022 and is headquartered in New York, NY.

Nano Nuclear Energy Inc.

NNE is drawing attention amid a steep selloff shared by other speculative nuclear and small-modular-reactor stocks, with traders debating whether the decline reflects sector-wide weakness or concerns about the companys early-stage, pre-revenue business and execution risks. Some are buying the dip on the long-term nuclear-power and AI data-center demand thesis, while others remain bearish after the sustained losses.

Marathon Petroleum Corp. engages in the refining, marketing, and transportation of petroleum products. It operates through the Refining and Marketing, and Midstream segments. The Refining and Marketing segment includes refining crude oil and other feedstocks, purchasing ethanol, and refined products for resale and distribution of refined products. The Midstream segment refers to transportation, storing, distribution, and marketing of crude oil and refined products. The company was founded in 1887 and is headquartered in Findlay, OH.

Marathon Petroleum Corp

MPC is drawing attention amid a powerful rally in refiners, with traders pointing to elevated crack spreads and tight refined-fuel supplies tied to geopolitical disruptions as support for refinery margins. The community is split between bullish momentum and expectations of a pullback, with some questioning whether unusually strong margins can last after the sectors sharp run.

Energy Transfer LP engages in natural gas pipeline transportation and transmission services. It operates through the following segments: Intrastate Transportation and Storage, Interstate Transportation and Storage, Midstream, NGL and Refined Products Transportation and Services, Crude Oil Transportation and Services, Investment in Sunoco LP, Investment in USAC, and All Other. The Intrastate Transportation and Storage segment owns and operates natural gas transportation pipelines. The Interstate Transportation and Storage segment includes transportation pipelines, storage facilities, and gathering systems and delivery of natural gas to industrial end-users and other pipelines. The Midstream segment consists of natural gas gathering, compression, treating, processing, storage, and transportation. The NGL and Refined Products Transportation segment engages in the operations transport, store and execute acquisition, and marketing activities utilizing a complementary network of pipelines, storage and blending facilities, and strategic off-take locations that provide access to multiple NGL markets. The Crude Oil Transportation and Services segment provides transportation, terminalling, acquisition, and marketing services to crude oil markets. The Investment in Sunoco LP segment refers to the distribution of motor fuels to independent dealers, distributors, and other commercial customers and the distribution of motor fuels to end-user customers at retail sites. The Investment in USAC segment offers compression services to its customers in connection with infrastructure applications including both allowing for the processing and transportation of natural gas through the domestic pipeline system and enhancing crude oil production through artificial lift processes. The company was founded by Kelcy L. Warren in 1996 and is headquartered in Dallas, TX.

Energy Transfer LP - Unit

Energy Transfer LP Unit

Strong quarterly results and outlook, along with Energy Transfers comments on natural-gas infrastructure opportunities for data centers and another distribution increase, are driving attention. Traders are broadly bullish on AI-related gas demand and income potential, though some are frustrated by the unit prices muted reaction.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX is drawing attention as shares reach fresh 52-week highs ahead of an expected, but unconfirmed, Q3 report, with traders watching BRIUMVIs sales momentum and whether results support the rally. Buyout and short-squeeze speculation is adding to bullish sentiment, though some traders see earnings and the commercial growth storynot an acquisitionas the main driver.

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is drawing attention as a proxy for private AI holdings, especially amid speculation about a potential Anthropic IPO. Bulls see the listing as a catalyst, while bears question the funds premium to NAV and point to dilution and claims that it reduced its Anthropic stake.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

A sharp selloff has put AEHRs valuation and upcoming fiscal first-quarter results in focus, with traders weighing broader weakness in AI and semiconductor stocks against concerns about the companys steep growth expectations. Bears point to put-heavy options activity and downside risk, while bulls argue the pullback may be overdone if AI chip-testing demand and FY2027 guidance hold up.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCaths Medicare reimbursement could fall sharply during 2027 has fueled concern about pricing and CorMedixs largest revenue driver. Traders are split between viewing the comments as a serious commercial risk and arguing that DaVitas estimates are preliminary and do not establish future CMS rates or company revenue.

Kimberly-Clark Corp. engages in the manufacture and marketing of products made from natural or synthetic fibers. It operates through North America and International Personal Care segments. The North America segment consists of products encompassing each of daily-need categories across consumer and professional channels including disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, facial and bathroom tissue, paper towels, napkins, wipers, tissue, towels, soaps and sanitizers and other related products. The International Personal Care segment consists of three core categories: Baby & Child Care, Adult Care, and Feminine Care, including disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear and other related products. The company was founded by John A. Kimberly, Havilah Babcock, Charles B. Clark, and Frank C. Shattuck in 1872 and is headquartered in Dallas, TX.

Kimberly-Clark Corp.

Kimberly-Clark is drawing attention after preliminary Q3 results topped expectations and the company reaffirmed its outlook; traders also point to easing Huggies-related concerns in China and progress toward financing and regulatory approval for the Kenvue acquisition. Reactions are constructive around defensive-staples demand and the mergers potential, though some remain wary of deal execution and the stocks recent weakness.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MetaVia to Present Phase 1 Clinical Trial Data for DA-1726 in Oral Presentation at the Precision Liver Symposium 2026

MetaVia to Present Phase 1 Clinical Trial Data for DA-1726 in Oral Presentation at the Precision Liver Symposium 2026 MetaVia to Present Phase 1 Clinical Trial Data for DA-1726 in Oral Presentation at the Precision Liver Symposium 2026PR NewswireCAMBRIDGE, Mass., Oct. 28, 2026 CAMBRIDGE, Mass...

MetaVia Appoints Sarah Browne As CMO

(RTTNews) - MetaVia Inc. (MTVA), a clinical-stage biotechnology company, on Tuesday announced the appointment of Sarah Browne as Chief Medical Officer, effective October 12...

MetaVia Appoints Seasoned Clinical Development Executive Sarah Browne, M.D., as Chief Medical Officer

MetaVia Appoints Seasoned Clinical Development Executive Sarah Browne, M.D., as Chief Medical Officer MetaVia Appoints Seasoned Clinical Development Executive Sarah Browne, M.D., as Chief Medical OfficerPR NewswireCAMBRIDGE, Mass., Oct. 13, 2026Brings Extensive Experience Leading Liver and...

MetaVia Announces Preclinical Findings Supporting Biological Rationale for DA-1726's Waist Circumference Reduction

MetaVia Announces Preclinical Findings Supporting Biological Rationale for DA-1726's Waist Circumference Reduction MetaVia Announces Preclinical Findings Supporting Biological Rationale for DA-1726's Waist Circumference Reduction PR Newswire CAMBRIDGE, Mass., Sept. 9, 2026 Tissue Distribution Study...

MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update

MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update PR Newswire CAMBRIDGE, Mass., Aug. 6, 2026 All Active Patients Successfully Reached Highest Planned Dose Levels of 48 mg and 64 mg...

MetaVia Announces Completion of Dose Titration in Phase 1 Part 3 Study of DA-1726 for the Treatment of Obesity

MetaVia Announces Completion of Dose Titration in Phase 1 Part 3 Study of DA-1726 for the Treatment of Obesity MetaVia Announces Completion of Dose Titration in Phase 1 Part 3 Study of DA-1726 for the Treatment of Obesity PR Newswire CAMBRIDGE, Mass., July 9, 2026 All Active Patients in Both...

MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Life Sciences Virtual Investor Forum

MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Life Sciences Virtual Investor Forum MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Life Sciences Virtual Investor Forum PR Newswire CAMBRIDGE, Mass., June 17, 2026 CAMBRIDGE, Mass., June 17, 2026...

MetaVia Presents New Late-Breaking Obesity and Metabolic Data at the ADA 2026 Scientific Sessions Supporting DA-1726 Differentiation and Vanoglipel Combination Potential

MetaVia Presents New Late-Breaking Obesity and Metabolic Data at the ADA 2026 Scientific Sessions Supporting DA-1726 Differentiation and Vanoglipel Combination Potential MetaVia Presents New Late-Breaking Obesity and Metabolic Data at the ADA 2026 Scientific Sessions Supporting DA-1726...

Biotech Stocks Are Loading Up on Major 2026 Catalysts and Wall Street Is Watching

Investors continue to focus on companies capable of generating meaningful clinical milestones, regulatory achievements, and commercial opportunities in large underserved markets. Several small-cap healthcare names now have potentially market-moving events scheduled throughout the remainder of 2026, positioning them among closely watched stocks in the biotech and healthcare sectors. $BCDA, $NTHI, $MTVA, $BGMS, $CMND

MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Emerging Growth Conference

MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Emerging Growth Conference MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Emerging Growth Conference PR Newswire CAMBRIDGE, Mass., June 4, 2026 CAMBRIDGE, Mass., June 4, 2026 /PRNewswire/ --MetaVia Inc...

MetaVia, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. Its pipeline includes ANA001, a proprietary oral niclosamide formulation, Gemcabene, which is assessed as an acute indication for COVID-19, NB-01, a treatment for painful diabetic neuropathy, and NB-02, which has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases. The company was founded on October 30, 2014 and is headquartered in Cambridge, MA.

MetaVia Inc.

IMG, MTVA, USREF, TGL: These Four Stocks Trade Ex-Reverse Split On Friday

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>CIMG will implement a 20-for-1 reverse stock split, effective December 5.</li><li>MetaVia’s 1-for-11 reverse stock split of common stock will come into effect on December 4.</li><li>Treasure Global said its 1-for-20 reverse stock split of common stock will come into effect on December 5.</li></ul>&nbsp;Companies often use reverse stock splits to maintain their stock exchange listing, as major exchanges require the stock’s price to trade above $1. Falling below that level for 30 straight trading days triggers a deficiency notice, and the company is given a limited window to lift the share price.A reverse split raises the stock’s price by reducing the share count, helping the company regain compliance and avoid delisting.On Friday, four stocks will begin trading post a reverse split:CIMG Inc. (IMG), a digital health and sales development company, is set for a 20-for-1 reverse stock split, which takes effect on December 5. Post-split, CIMG’s stock will continue trading on Nasdaq under the symbol “IMG.” The reverse split will reduce the company’s outstanding shares to around 15.5 million from approximately 310 million.The reverse split also applies to stock options and warrants, with fractional shares rounded up to the nearest whole share.On Thursday, <a href="https://stocktwits.com/symbol/IMG">IMG stock</a> was down 10%, while retail sentiment on Stocktwits remained in the ‘bearish’ zone over the past 24 hours.MetaVia Inc. (MTVA), a clinical-stage biotech company focused on cardiometabolic diseases, announced a 1-for-11 reverse stock split of its common stock, effective December 4, post-market hours.Starting December 5, MetaVia’s shares will trade on Nasdaq on a split-adjusted basis under the symbol “MTVA.” The reverse split reduces outstanding shares from around 25.4 million to 2.3 million.<a href="https://stocktwits.com/symbol/MTVA">MTVA stock</a> gained around 7% on Thursday, while retail sentiment on Stocktwits remained in the ‘bearish’ territory over the past 24 hours.Treasure Global Inc.&nbsp;(TGL) said its 1-for-20 reverse stock split of common stock will come into effect on December 5. The company’s shares will continue trading on Nasdaq under the symbol “TGL” on a split-adjusted basis.The reverse split reduces outstanding shares from around 17 million to 848,100 and aims to help the company regain compliance with Nasdaq’s $1 minimum bid price requirement.<a href="https://stocktwits.com/symbol/TGL">TGL shares</a> were up marginally on Thursday as retail sentiment on Stocktwits remained ‘bullish’ over the past 24 hours.&nbsp;Tactical Resources Corp.’s (USREF) 5-for-1 share consolidation will come into effect on December 5. The action will reduce the total outstanding shares to around 7.35 million.<a href="https://stocktwits.com/symbol/USREF">USREF shares</a> had climbed 1% as retail sentiment on Stocktwits remained in the ‘bullish’ zone.For updates and corrections, email newsroom[at]stocktwits[dot]com.

A reverse split raises the stock’s price by reducing the share count, helping the company regain compliance and avoid delisting.

CIMG Inc.

Treasure Global Inc

Tactical Resources Corp

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$1.12
Prev Close	$1.19
Open	$1.20
Dividend Yield	0.00%
50-Day Moving Average	$1.52
Beta	0.85
Avg. Volume	89,124.99
PE Ratio	-0.28

52-Week High	$14.85
52-Week Low	$0.9661
Market Capitalization	$7.38M
EPS (Annual)	-$7.35
Price to Book	1.08
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info

MTVA Fundamentals